🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the clinical efficacy and safety of certolizumab pegol as add-on ...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT00674362
Treatments Being Tested
This study is conducted to evaluate the short (12 Weeks) and long term (104...
Status
Completed
Location
141
Start Date
2011-12
Trial ID
NCT01500278
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of bimekizu...
Status
Completed
Location
As0013 908
Start Date
2017-10-04
Trial ID
NCT03215277
Treatments Being Tested
This study will characterize the pharmacokinetics (PK) of certolizumab pego...
Status
Completed
Location
1
Start Date
2015-03
Trial ID
NCT02365948
Treatments Being Tested
The primary objective is to assess differences in PASI scores between Week ...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00329303
Treatments Being Tested
To assess the clinical efficacy of subcutaneous (sc) certolizumab pegol adm...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00308581
Treatments Being Tested
The current study is designed to measure the corticosteroid-sparing effect ...
Status
Terminated
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00349752
Treatments Being Tested
The study is a Phase 3, multicenter, randomized, double-blind, placebo-cont...
Status
Completed
Location
961
Start Date
2010-03
Trial ID
NCT01087762
Treatments Being Tested
The objectives of this study are to verify the superiority in efficacy (Ame...
Status
Completed
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT00791921
Treatments Being Tested
A Randomized, Double-blind, Placebo Controlled Trial of Certolizumab Pegol ...
Status
Completed
Location
Philip C. Bosch, MD
Start Date
2015-12-15
Trial ID
NCT02497976
Treatments Being Tested